Global Parkinson?s Disease Therapeutics Market is anticipated to witness significant growth, owing to the increasing cases of Parkinson?s disease, with the growth in aging population levels. Furthermore, increasing environmental factors & genetic heredity is augmenting the growth of the Parkinson?s disease therapeutics market. Therefore, it may drastically result in expanding the market size during the forecast period. Pharmaceutical firms are creating new and improved therapies for Parkinson's disease (PD), and lately, there have been some significant product launches in Parkinson's disease therapeutics and other assistive therapeutics.